Business Description
Genprex Inc
NAICS : 325412
SIC : 2834
ISIN : US3724461047
Compare
Compare
Traded in other countries / regions
GNPX.USA2DE.Germany0A8I.UK IPO Date
2018-03-29Description
Genprex Inc is a clinical-stage gene therapy company. It is a clinical stage gene therapy company pioneering the development of gene-based therapies for large patient populations with unmet medical needs.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.76 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 9.4 | |||||
| 3-Year EPS without NRI Growth Rate | 8.8 | |||||
| 3-Year FCF Growth Rate | 8.8 | |||||
| 3-Year Book Growth Rate | 43.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.18 | |||||
| 9-Day RSI | 30.35 | |||||
| 14-Day RSI | 32.38 | |||||
| 6-1 Month Momentum % | -42.19 | |||||
| 12-1 Month Momentum % | -62.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | |||||
| Quick Ratio | 3.2 | |||||
| Cash Ratio | 2.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -133.23 | |||||
| ROA % | -116.56 | |||||
| ROIC % | -531.78 | |||||
| ROC (Joel Greenblatt) % | -124958.68 | |||||
| ROCE % | -134.15 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.53 | |||||
| Price-to-Tangible-Book | 1.6 | |||||
| EV-to-EBIT | -0.41 | |||||
| EV-to-EBITDA | -0.41 | |||||
| EV-to-FCF | -0.55 | |||||
| Price-to-Net-Current-Asset-Value | 2.2 | |||||
| Price-to-Net-Cash | 2.93 | |||||
| Earnings Yield (Greenblatt) % | -243.9 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GNPX
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genprex Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.62 | ||
| Beta | 0.07 | ||
| Volatility % | 50.25 | ||
| 14-Day RSI | 32.38 | ||
| 14-Day ATR ($) | 0.039409 | ||
| 20-Day SMA ($) | 0.459775 | ||
| 12-1 Month Momentum % | -62.7 | ||
| 52-Week Range ($) | 0.35 - 1.94 | ||
| Shares Outstanding (Mil) | 59.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genprex Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genprex Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genprex Inc Frequently Asked Questions
What is Genprex Inc(GNPX)'s stock price today?
The current price of GNPX is $0.35. The 52 week high of GNPX is $1.94 and 52 week low is $0.35.
When is next earnings date of Genprex Inc(GNPX)?
The next earnings date of Genprex Inc(GNPX) is 2023-11-14 Est..
Does Genprex Inc(GNPX) pay dividends? If so, how much?
Genprex Inc(GNPX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers